Chemed Corp. (NYSE: CHE) reported Q4 EPS of $1.97, $0.16 better than the analyst estimate of $1.81. Revenue for the quarter came in at $399 million versus the consensus estimate of $390.22 million.

GUIDANCE:

Chemed Corp. sees FY2016 EPS of $7.05-$7.25, versus the consensus of $7.31.

For earnings history and earnings-related data on Chemed Corp. (CHE) click here.